메뉴 건너뛰기




Volumn 63, Issue 7-8, 2010, Pages 247-251

The effect of Stalevo-dosing on quality of life of Parkinsonian patients with wearing-off;A Stalevo-adagolás hatása a wearing off tüneteket mutató Parkinson-kóros betegek életminocombining double acute accentségére

Author keywords

Dosing frequency; Quality of life; Stalevo

Indexed keywords

CATECHOL METHYLTRANSFERASE INHIBITOR; DECARBOXYLASE INHIBITOR; LEVODOPA; ANTIPARKINSON AGENT; CARBIDOPA; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CATECHOL DERIVATIVE;

EID: 77957662211     PISSN: 00191442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (10)
  • 1
    • 41549097751 scopus 로고    scopus 로고
    • Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: Implications from a clinical and patient perspective
    • Brooks DJ. Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective. Neuropsychiatr Dis Treat 2008;4:39-47. (Pubitemid 351460978)
    • (2008) Neuropsychiatric Disease and Treatment , vol.4 , Issue.1 A , pp. 39-47
    • Brooks, D.J.1
  • 2
    • 35348935657 scopus 로고    scopus 로고
    • Optimizing pharmacotherapy:strategies to manage the wearing-off phenomenon
    • Tse W. Optimizing pharmacotherapy:strategies to manage the wearing-off phenomenon. J Am Med Dir Assoc 2006;7(Suppl 2):12-7.
    • (2006) J Am Med Dir Assoc , vol.7 , Issue.SUPPL. 2 , pp. 12-17
    • Tse, W.1
  • 3
    • 53049098765 scopus 로고    scopus 로고
    • A folyamatos dopaminerg stimuláció jelentocombining double acute accentsége a Parkinson-kór kezelésében
    • Takáts A. A folyamatos dopaminerg stimuláció jelentocombining double acute accentsége a Parkinson-kór kezelésében. LAM 2008;18:585-9.
    • (2008) LAM , vol.18 , pp. 585-589
    • Takáts, A.1
  • 4
    • 26444616750 scopus 로고    scopus 로고
    • Optimising levodopa therapy for management of Parkinson's disease
    • Stocchi F. Optimising levodopa therapy for management of Parkinson's disease. J Neurol 2005;252(Suppl 4):IV43-48.
    • (2005) J Neurol , vol.252 , Issue.SUPPL. 4
    • Stocchi, F.1
  • 5
    • 44949206362 scopus 로고    scopus 로고
    • Levodopa/DDCI and entacapone is the preferred treatment for Parkinson's disease patients with motor fluctuations in routine practice: A retrospective, observational analysis of a large French cohort
    • DOI 10.1111/j.1468-1331.2008.02165.x
    • Damier P, Viallet F, Ziegler M, Bourdeix I, Rerat K. Levodopa/DDCI and entacapone is the preferred treatment for Parkinson's disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort. Eur J Neurol 2008;15:643-8. (Pubitemid 351814412)
    • (2008) European Journal of Neurology , vol.15 , Issue.7 , pp. 643-648
    • Damier, P.1    Viallet, F.2    Ziegler, M.3    Bourdeix, I.4    Rerat, K.5
  • 6
    • 34547191858 scopus 로고    scopus 로고
    • Medical management of levodopa-associated motor complications in patients with Parkinson's disease
    • DOI 10.2165/00023210-200721080-00005
    • Jankovic J, Stacy M. Medical management of levodopa-associated motor complications in patients with Parkinson's disease. CNS Drugs 2007;21:677-92. (Pubitemid 47121793)
    • (2007) CNS Drugs , vol.21 , Issue.8 , pp. 677-692
    • Jankovic, J.1    Stacy, M.2
  • 7
    • 43049164393 scopus 로고    scopus 로고
    • A Stalevo-kezelés magyarországi tapasztalatai és hatása a Parkinson-kórban szenvedõ betegek életminocombining double acute accentségére
    • Klivényi P, Vécsei L. A Stalevo-kezelés magyarországi tapasztalatai és hatása a Parkinson-kórban szenvedõ betegek életminocombining double acute accentségére. Ideggyógy Sz 2008;61:42-8.
    • (2008) Ideggyógy Sz , vol.61 , pp. 42-48
    • Klivényi, P.1    Vécsei, L.2
  • 9
    • 44949178691 scopus 로고    scopus 로고
    • Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease
    • DOI 10.2165/00023210-200822070-00003
    • Gallagher D, Schrag A. Impact of newer pharmacological treatments on quality of life in patients with Parkinson's Disease. CNS Drugs 2008:22(7):563-86. (Pubitemid 351822118)
    • (2008) CNS Drugs , vol.22 , Issue.7 , pp. 563-586
    • Gallagher, D.A.1    Schrag, A.2
  • 10
    • 3843063551 scopus 로고    scopus 로고
    • Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson's Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: Results of a large multicentre open-label study
    • Onofrij M, Thomas A, Vingerhoets F, Martin W, Giménez- Roldán S, Azulay JP, et al. Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson's Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multi-centre open-label study. J Neural Transm 2004:111:1053-63. (Pubitemid 39037126)
    • (2004) Journal of Neural Transmission , vol.111 , Issue.8 , pp. 1053-1063
    • Onofrj, M.1    Thomas, A.2    Vingerhoets, F.3    Martin, W.4    Gimenez-Roldan, S.5    Azulay, J.-P.6    Bernhard, G.7    Schmidt, W.8    Markabi, S.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.